This inventor holds 1 USPTO granted patent. Top assignee: Berlex Laboratories, Inc.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Ron H Bihovsky: A Pioneer in Pharmaceutical Innovations
Introduction:
Ron H Bihovsky, based in Convent Station, NJ (US), is a renowned inventor whose passion for innovation and relentless pursuit of excellence have inspired inventors and entrepreneurs worldwide. With a legacy deeply rooted in the world of technology, Bihovsky has made significant contributions to the field of pharmaceuticals, particularly in the area of endothelin conversion inhibitors.
Latest Patents:
With a remarkable patent titled "Inhibitors of the conversion of big endothelin to endothelin," Bihovsky introduces novel and known compounds that inhibit endothelin converting enzyme (ECE). This inhibition effectively prevents the conversion of Big Endothelin (BET) to Endothelin (ET), offering profound pharmaceutical utility and innovative preparations to the industry. This patent signifies Bihovsky's commitment to advancing medical science and improving patient outcomes.
Career Highlights:
Having secured one patent, Bihovsky's achievements speak volumes about his expertise and dedication to the field of pharmaceutical innovation. His affiliation with Berlex Laboratories, Inc. has provided him with a platform to bring his groundbreaking ideas to fruition, showcasing his proficiency in turning innovative concepts into tangible realities. Bihovsky's career highlights underscore his commitment to pushing the boundaries of pharmaceutical research and development.
Collaborations:
In his professional journey, Bihovsky has had the privilege of collaborating with esteemed colleagues such as Paul W Erhardt and John W Lampe. These collaborative efforts have not only enriched his own innovative pursuits but have also paved the way for collective advancement in the pharmaceutical industry. Bihovsky's ability to synergize with like-minded professionals underscores his collaborative spirit and commitment to driving collective success.
Conclusion:
Ron H Bihovsky's unwavering dedication to innovation and his significant contributions to pharmaceutical advancements solidify his legacy as a true pioneer in the field. Through his groundbreaking patent and collaborative endeavors, Bihovsky continues to inspire inventors and entrepreneurs globally, leaving an indelible mark on the world of technology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile